Luisa Beltran
EpimAb Biotherapeutics said June 5 that it raised $74 million in Series B funding co-led by by SDIC Fund and Sherpa Healthcare Partners. Also taking part in the round was SCVC, further private investment entities, and the A round investors. EpimAb, of Shanghai, China, is a biopharmaceutical company specializing in bispecific antibodies.
Matillion said June 4 that it raised a $35 million round of funding led by Battery Ventures. Also participating were Matillion’s Series B investors, Sapphire Ventures and Scale Venture Partners. Matillion, of Manchester, U.K., and Denver, Colorado, provides data transformation software for cloud data warehouses.
ADM Capital Europe said June 3 that it led a $5 million round for Moleaer. Existing investor Energy Innovation Capital participated in the round. Moleaer is developing industrial-scale nanobubble generators for indoor farming, metal separation, wastewater treatment and oil recovery.
ADM Capital Europe said June 3 that it led a $5 million round for Moleaer. Existing investor Energy Innovation Capital participated in the round. Moleaer is developing industrial-scale nanobubble generators for indoor farming, metal separation, wastewater treatment and oil recovery.
Robinhood Markets Inc is raising a $200 million round of funding, valuing the company at between $7 billion to $8 billion, Bloomberg reported. Existing investors are providing the latest cash infusion, the story said. Robinhood, of Menlo Park, California, provides free app-based trading.
Robinhood Markets Inc is raising a $200 million round of funding, valuing the company at between $7 billion to $8 billion, Bloomberg reported. Existing investors are providing the latest cash infusion, the story said. Robinhood, of Menlo Park, California, provides free app-based trading.
Alphamab Oncology said May 28 that it raised a $60 million Series B round led by Hudson Bay Capital Management LP. New investors including entrepreneur Adrian Cheng participated in the round, which included existing institutional investors such as China Venture Capital Fund (CVC), PAG, and Advantech Capital. Alphamab Oncology, of China, is a biopharmaceutical company developing biologics for cancer therapy.
Domain Therapeutics said May 28 that it secured a 3.5 million euros ($3.9 million) investment from existing shareholder Seventure Partners. Domain is a French biopharma company that is involved in the discovery and early development of programs targeting membrane receptors in central nervous system (CNS) disorders, oncology/immuno-oncology and rare diseases.
Domain Therapeutics said May 28 that it secured a 3.5 million euros ($3.9 million) investment from existing shareholder Seventure Partners. Domain is a French biopharma company that is involved in the discovery and early development of programs targeting membrane receptors in central nervous system (CNS) disorders, oncology/immuno-oncology and rare diseases.
Lion Street said May 22 that it completed a recapitalization of the company which returned equity the firm and its owners. Lion Street, of Austin, provides life insurance services. The company has raised $11.1 million in funding, from investors including Austin Ventures, PitchBook said.